Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

ICOSLG Antikörper (AA 23-149)

Der Maus Monoklonal Anti-ICOSLG-Antikörper wurde für ELISA, IHC, Coat, StM und ISt validiert. Er ist geeignet, ICOSLG in Proben von Human zu detektieren.
Produktnummer ABIN6939408

Kurzübersicht für ICOSLG Antikörper (AA 23-149) (ABIN6939408)

Target

Alle ICOSLG Antikörper anzeigen
ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

Reaktivität

  • 93
  • 17
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 50
  • 47
  • 8
  • 1
Maus

Klonalität

  • 64
  • 41
  • 1
Monoklonal

Konjugat

  • 62
  • 10
  • 7
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser ICOSLG Antikörper ist unkonjugiert

Applikation

  • 48
  • 41
  • 40
  • 34
  • 20
  • 16
  • 9
  • 8
  • 4
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Immunohistochemistry (IHC), Coating (Coat), Staining Methods (StM), Immunostaining (ISt)

Klon

ICOSL-3260
  • Bindungsspezifität

    • 23
    • 7
    • 6
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 23-149

    Spezifität

    This MAb recognizes a protein of 36 kDa, identified as ICOS-L. It is a ligand for the ICOS receptor that initiates T and B cell proliferation and cytokine secretion. ICOS-L interactions play an essential role in T cell-dependent B cell activation in peripheral lymphoid organs such as spleen and lymph nodes. ICOS-L protein is present in myeloid leukocytes, and by Northern blot there are 2.4, 3.0, and 7.0 kb transcripts in brain, heart, kidney, and liver, with lower expression in colon and thymus, and a 1.1 kb transcript in leukocytes. Tumor necrosis factor alpha (TNF), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) enhance its expression. LPS-induced up-regulation of ICOS-L is dependent on the MyD88-dependent signaling pathway.

    Aufreinigung

    Purified by Protein A/G

    Immunogen

    Recombinant fragment of human ICOSLG (B7RP-1) protein (around aa 23-149) (exact sequence is proprietary)

    Isotyp

    IgG2b kappa
  • Applikationshinweise

    Positive Control: HL60, HuT78 and HUVEC cells. Prostate or Colon Carcinoma.

    Known Application: ELISA (For coating, order antibody without BSA),Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    200 μg/mL

    Buffer

    10 mM PBS with0.05 % BSA & 0.05 % azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Haltbarkeit

    24 months
  • Target

    ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))

    Andere Bezeichnung

    ICOSLG

    Molekulargewicht

    36kDa

    Gen-ID

    23308

    UniProt

    O75144

    Pathways

    Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Sie sind hier:
Chat with us!